Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

Visceral Leishmaniasis Mimicking Autoimmune Hepatitis, Primary Biliary Cirrhosis, and Systemic Lupus Erythematosus Overlap

  • Tunccan, Ozlem Guzel (Department of Clinical Microbiology and Infectious Diseases, Gazi University Hospital) ;
  • Tufan, Abdurrahman (Internal Medicine Department, Division of Rheumatology, Gazi University Hospital) ;
  • Telli, Gulcin (Department of Clinical Microbiology and Infectious Diseases, Gazi University Hospital) ;
  • Akyurek, Nalan (Department of Pathology, Gazi University Hospital) ;
  • Pamukcuoglu, Merve (Department of Hematology, Gazi University Hospital) ;
  • Yilmaz, Guldal (Department of Pathology, Gazi University Hospital) ;
  • Hizel, Kenan (Department of Clinical Microbiology and Infectious Diseases, Gazi University Hospital)
  • Received : 2012.01.30
  • Accepted : 2012.03.03
  • Published : 2012.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Visceral leishmaniasis (VL) is a life-threatening infection caused by Leishmania species. In addition to typical clinical findings as fever, hepatosplenomegaly, and cachexia, VL is associated with autoimmune phenomena. To date, VL mimicking or exacerbating various autoimmune diseases have been described, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and autoimmune hepatitis (AIH). Herein, we presented a patient with VL who had overlapping clinical features with SLE, AIH, as well as antimitochondrial antibody (AMA-M2) positive primary biliary cirrhosis.

Keywords

References

  1. Magıll AJ. Leishmania species: visceral (kala-azar), cutaneus, and mucocutaneous leishmaniasis. In: Mandell GL, Bennett JE, Dolin R, eds, Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, USA. Churchill Livingston. 2010, p 3463-3480.
  2. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
  3. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill 2010; 15: 19505.
  4. Galvao-Castro B, Sa Ferreira JA, Marzochi KF, Marzochi MC, Coutinho SG, Lambert PH. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis. Clin Exp Immunol 1984; 56: 58-66.
  5. Argov S, Jaffe CL, Krupp M, Slor H, Shoenfeld Y. Autoantibody production by patients infected with Leishmania. Clin Exp Immunol 1989; 76: 190-197.
  6. Arlet JB, Capron L, Pouchot J. Visceral leishmaniasis mimicking systemic lupus erythematosus. J Clin Rheumatol 2010; 16: 203-204.
  7. Voulgari PV, Pappas GA, Liberopoulos EN, Elisaf M, Skopouli FN, Drosos AA. Visceral leishmaniasis resembling systemic lupus erythematosus. Ann Rheum Dis 2004; 63: 1348-1349.
  8. Casato M, de Rosa FG, Pucillo LP, Ilardi I, di Vico B, Zorzin LR, Sorgi ML, Fiaschetti P, Coviello R, Laganà B, Fiorilli M. Mixed cryoglobulinemia secondary to visceral leishmaniasis. Arthritis Rheum 1999; 42: 2007-2011.
  9. Dalgic B, Dursun I, Akyol G. A case of visceral leishmaniasis misdiagnosed as autoimmune hepatitis. Turk J Gastroenterol 2005; 16: 52-53.
  10. Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006; 43: 917-924.
  11. Alioglu B, Avci Z, Ozyurek E, Ozbek N. Visceral leishmaniasis presented with Evans syndrome: A case report. Am J Hematol 2007; 82: 1030-1031.
  12. Erduran E, Bahadir A, Gedik Y. Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B. Pediatr Hematol Oncol 2005; 22: 349-355.
  13. Yazici P, Yeniay L, Aydin U, Tasbakan M, Ozutemiz O, Yilmaz R. Visceral leishmaniasis as a rare cause of granulomatosis hepatitis: A case report. Turkiye Parazitol Derg 2008; 32: 12-15.
  14. Sakkas LI, Boulbou M, Kyriakou D, Makri I, Sinani C, Germenis A, Stathakis N. Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus. Clin Biochem 2008; 41: 65-68.
  15. Atta AM, Carvalho EM, Jerônimo SM, Sousa Atta ML. Serum markers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody. J Autoimmun 2007; 28: 55-58.

Cited by

  1. Immunity to visceral leishmaniasis: implications for immunotherapy vol.9, pp.7, 2012, https://doi.org/10.2217/fmb.14.43
  2. Visceral Leishmaniasis without Fever in an 11-Month-Old Infant: a Rare Clinical Feature of Kala-azar vol.52, pp.2, 2014, https://doi.org/10.3347/kjp.2014.52.2.189
  3. Interplay of Infections, Autoimmunity, and Immunosuppression in Systemic Lupus Erythematosus vol.33, pp.4, 2014, https://doi.org/10.3109/08830185.2013.863305
  4. Pathogen Infection as a Possible Cause for Autoimmune Hepatitis vol.33, pp.4, 2012, https://doi.org/10.3109/08830185.2014.921162
  5. Clinical Characteristics of Concomitant Systemic Lupus Erythematosus and Primary Biliary Cirrhosis: A Literature Review vol.2015, pp.None, 2012, https://doi.org/10.1155/2015/713728
  6. Autoantibodies in a Three-Year-Old Girl with Visceral Leishmaniasis: A Potential Diagnostic Pitfall vol.2016, pp.None, 2012, https://doi.org/10.1155/2016/2081616
  7. Hematological Characteristics of Yemeni Adults and Children with Visceral Leishmaniasis. Could Eosinopenia be a Suspicion Index? vol.9, pp.1, 2012, https://doi.org/10.4084/mjhid.2017.056
  8. Visceral leishmaniasis mimicking systemic lupus erythematosus vol.52, pp.None, 2012, https://doi.org/10.1590/0037-8682-0208-2018
  9. Pathogens and autoimmune hepatitis vol.195, pp.1, 2012, https://doi.org/10.1111/cei.13203